SOLICITATION NOTICE
R -- Drug Induced Liver Injury Focus Group Planning Services-Biosimulation Methodologies - Performance Work Statement
- Notice Date
- 8/18/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 09-223-SOL-00225
- Archive Date
- 8/27/2009
- Point of Contact
- Aaron A. Glazier, Phone: 8705437577
- E-Mail Address
-
aaron.glazier@fda.hhs.gov
(aaron.glazier@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- RFP Liver Specs- Performance Work Statement- FDA would like to bring the benefits of biosimulation methodologies to the field of Drug Induced Liver Injury. See the attached Solicitation and Performance Work Statement for additional details.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/09-223-SOL-00225/listing.html)
- Place of Performance
- Address: Silver Springs, Maryland, United States
- Record
- SN01915943-W 20090820/090819000338-f9c974ee590a27118c8be155742a5aed (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |